About

Unlocking targeted medicines with our transformative mRNA platform 

Company Vision

Combined Therapeutics Inc. (CTx) is a privately held biotechnology company developing the next generation of high-value mRNA vaccines to protect everyone, including vulnerable populations, from global infectious diseases as well as to treat cancer.

Our unique and proprietary mRNA platform, with an increased safety profile due to controlled biodistribution and high specificity, is built around Multi Organ Protective (MOPCTx) binding miRNA sequences combined with therapeutic mRNAs, allowing the targeting of therapeutic protein expression in specific tissues while reducing off-target effects to protect key vital organs such as the heart, liver, and kidneys.

Our initial focus is on developing vaccines and vaccine adjuvants for infectious diseases and oncology indications, with plans to initiate clinical development in 2024.

Founders

Romain Micol, M.D., MPH, Ph.D., MBA, LLM

President and Chief Executive Officer (co-founder), Board Director

×
×
×

Operational Team

Romain Micol, M.D., MPH, Ph.D., MBA, LLM

President and Chief Executive Officer (co-founder), Board Director

Valerie Duval, Ph.D.

Director, Molecular Biology and mRNA Platform Development

Lauren Speciner, Ph.D.

Associate Director, Formulation & Process Development

Pierre Vochel

Senior Manager, Finance & Strategy

Roberto Molina

Scientist, Molecular Biology and mRNA Platform Development

Asad Khanmohammed

Associate Scientist, Formulation & Process Development

Kimberly Foster, MLS(ASCP)CM

Associate Scientist, Molecular Biology and mRNA Platform Development

Grace Gallagher

Research Associate, Molecular Biology and mRNA Platform Development

Walter James

Lab Manager

Ejiro Gbaje, MPH

Biostatistician, Soladis

David Neafus, MBA

Financial Advisor, Triton Resources

Ronald E. Kaunfer

Accounting Director, Triton Resources

Devenand Crease, Ph.D.

Patent attorney, Keltie

Sarah Cooleybeck, JD

Corporate Attorney, Foley-Hoag

David Renauld, JD

Corporate Attorney, Foley-Hoag

Lisa Haile, Ph.D., JD

Patent Attorney, DLA Piper

Board of Directors

Pierre Matussiere

Board Director

×
×

Romain Micol, M.D., MPH, Ph.D., MBA, LLM

President and CEO (co-founder), Board Director

×
×

Paul Wotton, Ph.D

Board Director

×